Exact Mass: 276.0778

Exact Mass Matches: 276.0778

Found 30 metabolites which its exact mass value is equals to given mass value 276.0778, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Biotin sulfone

5-[(3aS,4S,6aR)-2,5,5-trioxo-hexahydro-1H-5λ⁶-thieno[3,4-d]imidazolidin-4-yl]pentanoic acid

C10H16N2O5S (276.078)


Biotin sulfone is a natural biotin metabolite in human urine. (PMID 9039841). The urinary excretion of biotin sulfone a increased with biotin administration. (PMID 9022537). Biotin sulfone is first isolated as a natural metabolite of biotin.

   

1-Phenyl-1,4-epoxy-1h,4h-naphtho[1,8-de][1,2]dioxepin

10-phenyl-11,12,15-trioxatetracyclo[7.4.1.1^{10,13}.0^{5,14}]pentadeca-1,3,5(14),6,8-pentaene

C18H12O3 (276.0786)


   

Tanshinone I

6,14-dimethyl-12-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(10),2(7),3,5,8,11(15),13-heptaene-16,17-dione

C18H12O3 (276.0786)


   

TTE-50

InChI=1/C18H12O3/c1-9-4-3-5-12-11(9)6-7-13-15(12)17(20)16(19)14-10(2)8-21-18(13)14/h3-8H,1-2H3

C18H12O3 (276.0786)


Tanshinone I is an abietane diterpenoid. It has a role as an anticoronaviral agent. Tanshinone I is a natural product found in Salvia miltiorrhiza, Salvia digitaloides, and other organisms with data available. See also: Salvia Miltiorrhiza Root (part of). D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants D000893 - Anti-Inflammatory Agents D000890 - Anti-Infective Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM).

   

6,8-Dihydroxy-4-methyl-7H-benz[de]anthracen-7-one

6,8-Dihydroxy-4-methyl-7H-benz[de]anthracen-7-one

C18H12O3 (276.0786)


   

Isotanshinone II

Isotanshinone II

C18H12O3 (276.0786)


   

3-Hydroxy-4-phenyl-1H,3H-naphtho[1,8-cd]pyran-1-one

3-Hydroxy-4-phenyl-1H,3H-naphtho[1,8-cd]pyran-1-one

C18H12O3 (276.0786)


   

tanshinone I

tanshinone I

C18H12O3 (276.0786)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants D000893 - Anti-Inflammatory Agents D000890 - Anti-Infective Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM).

   

gamma-glutamyl-S-ethenylcysteine

gamma-glutamyl-S-ethenylcysteine

C10H16N2O5S (276.078)


   

SCHEMBL17867067

SCHEMBL17867067

C18H12O3 (276.0786)


   

CHEMBL477331

CHEMBL477331

C18H12O3 (276.0786)


   

6,8-dihydroxy-4-methyl-7 h-benz(de) anthracen-7-one

6,8-dihydroxy-4-methyl-7 h-benz(de) anthracen-7-one

C18H12O3 (276.0786)


   

Isotanshinone I

Isotanshinone I

C18H12O3 (276.0786)


   

(S,S)-gamma-glutamyl-(cis-S-1-propenyl)thioglycine|gamma-glutamyl-cis-S-1-propenyl-L-cysteine

(S,S)-gamma-glutamyl-(cis-S-1-propenyl)thioglycine|gamma-glutamyl-cis-S-1-propenyl-L-cysteine

C10H16N2O5S (276.078)


   

8-methoxy-1,2-methylenedioxypyrene

8-methoxy-1,2-methylenedioxypyrene

C18H12O3 (276.0786)


   

Biotin sulfone

Biotin sulfone

C10H16N2O5S (276.078)


A member of the class of biotins that is biotin sulfoxide with a sulfone group replacing the sulfoxide. Biotin sulfone is first isolated as a natural metabolite of biotin.

   

3-benzoylnaphthalene-2-carboxylic acid

3-benzoylnaphthalene-2-carboxylic acid

C18H12O3 (276.0786)


   

N-(4-methoxyphenyl)benzene-1,4-diamine; sulfuric acid

N-(4-methoxyphenyl)benzene-1,4-diamine; sulfuric acid

C13H13ClN4O (276.0778)


   

2-(1-Naphthoyl)benzoic acid

2-(1-Naphthoyl)benzoic acid

C18H12O3 (276.0786)


   

Oxifungin hydrochloride

Oxifungin hydrochloride

C13H13ClN4O (276.0778)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Tanshinon I

1,6-dimethylnaphtho[1,2-g][1]benzoxole-10,11-dione

C18H12O3 (276.0786)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants D000893 - Anti-Inflammatory Agents D000890 - Anti-Infective Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM).

   

4-Benzoyl-6-phenyl-2H-pyran-2-one

4-Benzoyl-6-phenyl-2H-pyran-2-one

C18H12O3 (276.0786)


   

3,8-dimethylphenanthro[4,3-b]furan-4,5-dione

3,8-dimethylphenanthro[4,3-b]furan-4,5-dione

C18H12O3 (276.0786)


   

(2s)-2-amino-4-{[(1s)-1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1s)-1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H16N2O5S (276.078)


   

4,8-dimethylphenanthro[3,2-b]furan-7,11-dione

4,8-dimethylphenanthro[3,2-b]furan-7,11-dione

C18H12O3 (276.0786)


   

2-amino-4-{[1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

2-amino-4-{[1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H16N2O5S (276.078)


   

6,10-dihydroxy-11-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

6,10-dihydroxy-11-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

C18H12O3 (276.0786)


   

6,10-dihydroxy-12-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

6,10-dihydroxy-12-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

C18H12O3 (276.0786)


   

6,10-dihydroxy-4-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one

6,10-dihydroxy-4-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one

C18H12O3 (276.0786)


   

(2s)-2-amino-4-{[(1r)-1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H16N2O5S (276.078)